Inflammatory biomarker may indicate coronary lesion

08/19/2013 | MedPage Today (free registration)

A study that used intravascular ultrasound and optical coherence tomography found the biomarker pentraxin 3 could serve as a red flag that patients are at risk of heart attack, researchers argue in JACC: Cardiovascular Interventions. Also in this article, using carotid intima-media thickness to determine vascular age and combining it with the Framingham risk score could help identify patients at risk of a severe heart attack, according to a report published in the journal Echocardiography.

View Full Article in:

MedPage Today (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Corporate Life Sciences Lawyer (3-5 years exp)
Ropes & Gray LLP
Boston, MA; San Francisco, CA; Silicon Valley, CA, MA
Director of Accreditation
Meridian Health Plan
Detroit, MI
Health Services Researcher
AARP
Washington, DC
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO
Senior director risk adjustor and coding doc
Novant Health
Charlotte, NC